Sabina Y van der Zanden

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

Proceedings of the National Academy of Sciences of the United States of America

Cancers

Journal of immunology (Baltimore, Md. : 1950)

Leiden University Medical Center

VU University Amsterdam (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center Jun 01 2016

Netherlands

Phd Student :: Cell and Chemical Biology - Chemical Immunology

Netherlands Cancer Institute Sep 01 2014 - May 31 2016

Netherlands

phd student :: Cell Biology II

Education History

VU University Amsterdam Sep 01 2012 - Aug 30 2014

Netherlands

MSC :: Biomolecular Science

Publications

Merle A van Gelder, Yufeng Li, Dennis P A Wander, Ilana Berlin, Hermen S Overkleeft, Sabina Y van der Zanden, Jacques J C Neefjes
Novel N,N -Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant Cells. Journal of medicinal chemistry 67 (16) (2024)
Merle A van Gelder, Yufeng Li, Dennis P A Wander, Ilana Berlin, Hermen S Overkleeft, Sabina Y van der Zanden, Jacques J C Neefjes
Novel N,N -Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant Cells. Journal of medicinal chemistry 67 (16) (2024)
Merle A van Gelder, Yufeng Li, Dennis P A Wander, Ilana Berlin, Hermen S Overkleeft, Sabina Y van der Zanden, Jacques J C Neefjes
Novel N,N -Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant Cells. Journal of medicinal chemistry 67 (16) (2024)
Merle A van Gelder, Yufeng Li, Dennis P A Wander, Ilana Berlin, Hermen S Overkleeft, Sabina Y van der Zanden, Jacques J C Neefjes
Novel N,N -Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant Cells. Journal of medicinal chemistry (2024)
Ruud H Wijdeven, Sietse J Luk, Tom A W Schoufour, Sabina Y van der Zanden, Marta Cabezuelo, Mirjam H M Heemskerk, Jacques J C Neefjes
Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. Journal of immunology (Baltimore, Md. : 1950) (2023)
Yumeng Wang, Sabina Y van der Zanden, Suzanne van Leerdam, Mayke M H Tersteeg, Anneke Kastelein, Stephan Michel, Jacques Neefjes, Johanna H Meijer, Tom de Boer
Induction of Fatigue by Specific Anthracycline Cancer Drugs through Disruption of the Circadian Pacemaker. Cancers 14 (10) (2022)
Xiaohang Qiao, Sabina Y van der Zanden, Dennis P A Wander, Daniel M Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne van Duikeren, Noortje van Gils, Arjo Rutten, Tessa van Herwaarden, Olaf van Tellingen, Elisa Giacomelli, Milena Bellin, Valeria Orlova, Leon G J Tertoolen, Sophie Gerhardt, Jimmy J Akkermans, Jeroen M Bakker, Charlotte L Zuur, Baoxu Pang, Anke M Smits, Christine L Mummery, Linda Smit, Ramon Arens, Junmin Li, Herman S Overkleeft, Jacques Neefjes
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin. Proceedings of the National Academy of Sciences of the United States of America 117 (26) (2020)
Sabina Y van der Zanden, Xiaohang Qiao, Jacques J C Neefjes
New insights into the activities and toxicities of the old anticancer drug doxorubicin. The FEBS journal 288 (21) (2020)
Dennis P A Wander, Sabina Y van der Zanden, Gijsbert A van der Marel, Herman S Overkleeft, Jacques J C Neefjes, Jeroen D C Codée
Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents. Journal of medicinal chemistry 63 (21) (2020)

Sabina Y van der Zanden.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sabina Y van der Zanden